SCHEMBL13775477

SCHEMBL13775477

COc1cccc(C(=O)c2cc(Cl)ccc2-n2cc(C=C(C)C)cc2C=O)c1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 1/20 0.38
FNTB P49356 1/20 0.38
FDFT1 P37268 1/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TUBB4A P04350 4/20 0.35
TUBB P07437 4/20 0.35
TUBA3C P0DPH7 4/20 0.35
TUBA1B P68363 4/20 0.35
TUBA4A P68366 4/20 0.35
TUBB4B P68371 4/20 0.35
TUBB3 Q13509 4/20 0.35
TUBB2A Q13885 4/20 0.35
TUBB8 Q3ZCM7 4/20 0.35
TUBA3E Q6PEY2 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4117359 0.93 ALDH1A1 (0.38) FNTAFNTBFDFT1KDM4ENPC1
SCHEMBL4117362 0.93 ALDH1A1 (0.38) FNTAFNTBFDFT1KDM4ENPC1
SCHEMBL4121567 0.89 KDM4E (0.35) KDM4ENPC1ALDH1A1LMNARAB9A
SCHEMBL4121572 0.89 KDM4E (0.35) KDM4ENPC1ALDH1A1LMNARAB9A
SCHEMBL4110749 0.84 GAA (0.39)
SCHEMBL13775474 0.84 FNTA (0.38) FNTAFNTBFDFT1KDM4ENPC1
SCHEMBL4123934 0.83 GAA (0.51) FNTAFNTBKDM4ENPC1ALDH1A1
SCHEMBL4109596 0.82 TUBB4A (0.41) FNTAFNTBKDM4ENPC1ALDH1A1
SCHEMBL4112006 0.79 ALDH1A1 (0.39) FNTAFNTBFDFT1KDM4ENPC1
SCHEMBL4112003 0.79 ALDH1A1 (0.39) FNTAFNTBFDFT1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR FNTA 528/4885FNTB 814/4885FDFT1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.